Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 1
2011 2
2012 3
2013 5
2014 4
2015 3
2016 4
2017 1
2018 4
2019 5
2020 11
2021 12
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
Lebrun-Frénay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F, Vermersch P, Papeix C, Thouvenot E, Labauge P, Durand-Dubief F, Efendi H, Le Page E, Terzi M, Derache N, Bourre B, Hoepner R, Karabudak R, De Seze J, Ciron J, Clavelou P, Wiertlewski S, Turan OF, Yucear N, Cohen M, Azevedo C, Kantarci OH, Okuda DT, Pelletier D; TERIS Study Group. Lebrun-Frénay C, et al. Among authors: derache n. JAMA Neurol. 2023 Oct 1;80(10):1080-1088. doi: 10.1001/jamaneurol.2023.2815. JAMA Neurol. 2023. PMID: 37603328 Free article. Clinical Trial.
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome.
Lebrun-Frénay C, Rollot F, Mondot L, Zephir H, Louapre C, Le Page E, Durand-Dubief F, Labauge P, Bensa C, Thouvenot E, Laplaud D, de Seze J, Ciron J, Bourre B, Cabre P, Casez O, Ruet A, Mathey G, Berger E, Moreau T, Al Khedr A, Derache N, Clavelou P, Guennoc AM, Créange A, Neau JP, Tourbah A, Camdessanché JP, Maarouf A, Callier C, Vermersch P, Kantarci O, Siva A, Azevedo C, Makhani N, Cohen M, Pelletier D, Okuda D, Vukusic S; RISC, SFSEP, and OFSEP Investigators. Lebrun-Frénay C, et al. Among authors: derache n. JAMA Netw Open. 2021 Oct 1;4(10):e2128271. doi: 10.1001/jamanetworkopen.2021.28271. JAMA Netw Open. 2021. PMID: 34633424 Free PMC article.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, Bittner S, Hartung HP, Friese MA, Linker RA, Luessi F, Lehmann-Horn K, Mühlau M, Paul F, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber F, Wildemann B, Zettl UK, Ziemann U, Müller-Myhsok B, Kümpfel T, Klotz L, Meuth SG, Zipp F, Hemmer B, Hohlfeld R, Brassat D, Gold R, Gross CC, Lukas C, Groppa S, Loser K, Wiendl H, Schwab N; German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network. Ostkamp P, et al. Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2018457118. doi: 10.1073/pnas.2018457118. Proc Natl Acad Sci U S A. 2021. PMID: 33376202 Free PMC article.
Organization of care for multiple sclerosis in France.
Derache N, Dufay A, Lebarbey C. Derache N, et al. Rev Neurol (Paris). 2018 Jun;174(6):475-479. doi: 10.1016/j.neurol.2018.01.366. Epub 2018 Apr 22. Rev Neurol (Paris). 2018. PMID: 29685429 Review.
Anti-Argonaute antibodies as a potential biomarker in NMOSD.
Carta S, Le Duy D, Rogemond V, Derache N, Chaumont H, Fromont A, Cabasson S, Boudot de la Motte M, Honnorat J, Marignier R. Carta S, et al. Among authors: derache n. J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):738-741. doi: 10.1136/jnnp-2022-330707. Epub 2023 Feb 21. J Neurol Neurosurg Psychiatry. 2023. PMID: 36810322
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
Januel E, De Seze J, Vermersch P, Maillart E, Bourre B, Pique J, Moisset X, Bensa C, Maarouf A, Pelletier J, Vukusic S, Audoin B, Louapre C; COVISEP Investigators. Januel E, et al. Mult Scler. 2022 Jun;28(7):1155-1159. doi: 10.1177/13524585211049737. Epub 2021 Dec 21. Mult Scler. 2022. PMID: 34931885
Heterozygous HTRA1 nonsense or frameshift mutations are pathogenic.
Coste T, Hervé D, Neau JP, Jouvent E, Ba F, Bergametti F, Lamy M, Cogez J, Derache N, Schneckenburger R, Grelet M, Gollion C, Lanotte L, Lauer V, Layet V, Urbanczyk C, Didic M, Raynouard I, Delaval L, Dassa J, Florea A, Badiu C, Nguyen K, Tournier-Lasserve E. Coste T, et al. Among authors: derache n. Brain. 2021 Oct 22;144(9):2616-2624. doi: 10.1093/brain/awab271. Brain. 2021. PMID: 34270682
Neurologic manifestations associated with COVID-19: a multicentre registry.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T; contributors to the NeuroCOVID registry. Meppiel E, et al. Clin Microbiol Infect. 2021 Mar;27(3):458-466. doi: 10.1016/j.cmi.2020.11.005. Epub 2020 Nov 13. Clin Microbiol Infect. 2021. PMID: 33189873 Free PMC article.
The long-term outcome of MOGAD: An observational national cohort study of 61 patients.
Deschamps R, Pique J, Ayrignac X, Collongues N, Audoin B, Zéphir H, Ciron J, Cohen M, Aboab J, Mathey G, Derache N, Laplaud D, Thouvenot E, Bourre B, Ruet A, Durand-Dubief F, Touitou V, Vignal-Clermont C, Papeix C, Gout O, Marignier R, Maillart E; NOMADMUS study group. Deschamps R, et al. Among authors: derache n. Eur J Neurol. 2021 May;28(5):1659-1664. doi: 10.1111/ene.14746. Epub 2021 Feb 19. Eur J Neurol. 2021. PMID: 33528851
49 results